CLIMB BIO INC. - COMMON STOCK

Eliem Therapeutics to Participate at Two Upcoming Investor Conferences

08 Nov 2022 06:00:02 By Nasdaq GlobeNewswire

Eliem Therapeutics Provides Update on Pipeline Progress

05 Oct 2022 06:00:00 By Nasdaq GlobeNewswire

Eliem Therapeutics Reports Second Quarter Financial and Business Highlights

15 Aug 2022 05:10:00 By Nasdaq GlobeNewswire

Eliem Therapeutics Provides ETX-810 Program Update

02 Aug 2022 06:00:01 By Nasdaq GlobeNewswire

Eliem Announces Updated Development Plans and the Advancement of ETX-155 for the Treatment of Major Depressive Disorder

18 Jul 2022 06:00:00 By Nasdaq GlobeNewswire

Eliem Therapeutics to Host Virtual Investor Event on July 21, 2022

07 Jul 2022 06:00:00 By Nasdaq GlobeNewswire

Eliem Therapeutics Announces Last Patient Completed Dosing in Phase 2a Study of ETX-810 in Patients with Lumbosacral Radicular Pain (LSRP)

27 Jun 2022 15:01:00 By Nasdaq GlobeNewswire

Eliem Therapeutics Reports First Quarter Financial and Business Highlights

16 May 2022 05:10:00 By Nasdaq GlobeNewswire

Eliem Provides Update on ETX-810 and ETX-155 Clinical Programs

25 Apr 2022 06:00:00 By Nasdaq GlobeNewswire

Eliem Therapeutics Appoints Susan Franks as Senior Vice President and Head of Regulatory Affairs

05 Apr 2022 06:00:01 By Nasdaq GlobeNewswire

Eliem Therapeutics to Present at Stifel’s 2022 CNS Days

21 Mar 2022 06:00:00 By Nasdaq GlobeNewswire

Eliem Therapeutics Reports Fourth Quarter and Year-End Financial and Business Highlights

07 Mar 2022 15:10:00 By Nasdaq GlobeNewswire

Eliem Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

11 Feb 2022 06:00:00 By Nasdaq GlobeNewswire

Eliem Therapeutics Host Virtual Investor Event Featuring Opinion Leaders in Chronic Pain Research on February 16, 2022

07 Feb 2022 06:00:00 By Nasdaq GlobeNewswire

Eliem Therapeutics Provides Program Updates and an Overview of Expected Near-Term Milestones

18 Jan 2022 06:00:01 By Nasdaq GlobeNewswire

Eliem Therapeutics Reports Third Quarter Financial and Business Highlights

08 Nov 2021 15:01:00 By Nasdaq GlobeNewswire

Eliem Therapeutics to Participate at Four Upcoming Investor Conferences

04 Nov 2021 06:00:01 By Nasdaq GlobeNewswire

Eliem Therapeutics Reports Second Quarter Financial Results

13 Sep 2021 15:10:00 By Nasdaq GlobeNewswire

Eliem Therapeutics Announces Closing of Initial Public Offering with Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

12 Aug 2021 20:06:11 By Nasdaq GlobeNewswire

Eliem Therapeutics Announces Pricing of Initial Public Offering

09 Aug 2021 21:33:09 By Nasdaq GlobeNewswire